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Abstract 
 
HEMODYNAMICS AND SLEEP ARCHITECTURE FOLLOWING ACUTE 
ALCOHOL CONSUMPTION IN COLLEGE AGE MALES 
 
Daniel Keith Payseur 
B.S., Appalachian State University 
M.S., Appalachian State University 
 
 
Chairperson:  Scott R. Collier 
 
 
Hypertension-associated cardiovascular disease (CVD) is the leading cause of 
morbidity and mortality in the Western world (Kochanek et al., 2011).  Hypertension is a 
progressive disease characterized by elevated blood pressures which can cause damage to 
arteries and increases afterload leading to myocardial remodeling and a progressively 
worsening cardiovascular function.  This increase in afterload requires an increase in 
contractility which further results in higher blood pressures.   Many factors, including 
alcohol consumption, can exacerbate these symptoms and have been shown to accelerate the 
disease process.  The effects of alcohol ingestion can range from decreases in arterial 
compliance to heightened nocturnal blood pressure.  When nocturnal blood pressure does 
not dip (decrease below average resting values), the impact is realized with increases in all-
cause morbidity and mortality.  The reduction or elimination of a dip in blood pressure has 
been shown to be strongly correlated with many forms of cardiovascular disease. 
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Heightened nocturnal blood pressure may be attributed to the disruption of sleep architecture, 
which is a condition worsened by alcohol ingestion; however, little is known regarding the 
effects of alcohol ingestion on sleep architecture and nocturnal blood pressure.  The purpose 
of this study was to investigate the effects of acute alcohol ingestion on hemodynamics and 
sleep architecture in a young, healthy cohort.  Seventeen male subjects (N=17) underwent 
acute alcohol ingestion reaching a breath alcohol content of 0.08.  Following alcohol 
treatment, each subject underwent a battery of hemodynamic tests and had their sleep 
architecture and nocturnal blood pressure monitored pre- and post-treatment.  Aortic systolic 
blood pressures were found to be significantly increased following acute alcohol ingestion.  
Nocturnal systolic blood pressure was also found to be increased significantly following 
acute alcohol ingestion.  Nocturnal systolic dip was found not to be significantly decreased. 
Percentage of time in deep sleep and number of awakenings showed no significant 
differences between pre- and post measures.  This study showed a significant increase in 
aortic systolic blood pressure and nocturnal systolic blood pressure.  The increased workload 
brought on by these pressure changes may increase the risk of developing cardiovascular 
disease due to hypertension.  
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 The research detailed in this thesis will be submitted to Alcohol and Alcoholism, the 
official journal of the Medical Council on Alcohol.  The thesis has been prepared according 
to the guidelines set forth by the Graduate School of Appalachian State University.  
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Introduction 
Many factors affect cardiovascular health.  Whether these are results of life choices 
or intrinsic factors, many of them can result in various forms of disease.  These factors 
include family history of cardiovascular disease, sedentary lifestyle, obesity, alcohol 
consumption, smoking, and many more (Pajak and Kawalec, 2005).  No matter the 
mechanism, most risk factors lead to hypertension, thus making hypertension-associated 
cardiovascular disease (CVD) the leading cause of morbidity and mortality in the Western 
world (Kochanek et al., 2011).  Hypertension is a progressive disease characterized by 
elevated blood pressures which can cause damage to arteries and increase afterload.  This 
increase in afterload requires an increase in contractility which results in higher blood 
pressures (Sunagawa, 2010). 
Young adults are not immune to this disease; and when manifested at an early age, 
high blood pressures can lead to more extensive forms of target organ damage, further 
increased blood pressure, and increased likelihood of other CVDs (Urbina et al., 2011).  
Higher blood pressure in early adulthood is also associated with elevated risk of all-cause 
mortality as well as CVD several decades later (Gray et al., 2011).  In a young cohort, the 
presence of CVD is often accelerated by an external factor. Because of this, young men are 
at an increased risk of developing hypertension and other forms of CVD (Higashiyama et al., 
2012) due to consumption of alcohol (Le-Ha et al., 2012). 
High alcohol intake has been shown to lead to increases in arterial blood pressure 
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(Foerster et al., 2009, Keil et al., 1989) and a higher risk of cardiovascular disease (Steffens 
et al., 2006).  Alcohol consumption is associated with the progression of various forms of 
CVD (Higashiyama et al., 2012, Ohmori et al., 2002, Sull et al., 2010, Sundell et al., 2008, 
Yoshita et al., 2005) and prehypertension is observed at a higher frequency in college-aged 
populations (Gillman et al., 1995).  Further alcohol use has been shown to have an effect on 
young vasculature (Le-Ha et al., 2012).  Therefore, the link between alcohol consumption 
and prehypertension should be examined more closely. 
 Alcohol has multiple, deleterious effects on human hemodynamics.  These effects 
are shown by increases in arterial stiffness (Kurihara et al., 2004) and decreases in nocturnal 
blood pressure dipping (Seppa and Sillanaukee, 1999).  Nocturnal blood pressure dipping is 
a physiological method of maintaining health of the heart and the vascularity by decreasing 
myocardial demand which also provides a mechanism to combat chronic rises in blood 
pressure (Friedman and Logan, 2009).  During nocturnal dipping, baroreceptors reset and 
arterial turbulence decreases, instigating the relaxation of the vasculature.  Those who do not 
experience nocturnal blood pressure dipping are at an increased risk of hypertension 
(Cuspidi et al., 2011, Tsioufis et al., 2011), CVD (Mehta and Drawz, 2011, Napan et al., 
2011, Vasunta et al., 2012), and other forms of disease or dysfunction (Mehta and Drawz, 
2011, Moller et al., 2007, van de Borne et al., 1997).  Effects are often widespread and cause 
a multitude of event series which end in results such as kidney disease or further autonomic 
dysfunction. 
Nocturnal blood pressure dipping is paramount for one’s health and is unequivocally 
tied to sleep architecture.  Both are strong factors in determining cardiovascular health 
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(Arnedt et al., 2011, Sherwood et al., 2011).  Blood pressure dipping is seen at a lower 
frequency and duration when the number of sleep disturbances is increased making sleep 
interruptions a very strong predictor of cardiovascular events (Crum et al., 2004, Matthews 
et al., 2008).  Sleep architecture has a profound effect on blood pressure regulation both 
overnight and during daytime hours (Fung et al., 2011, Lanfranchi et al., 2009, 
Sabanayagam and Shankar, 2010).  More specifically, alcohol has been shown to affect sleep 
quality in a young adult population (Ehlers et al., 2010).  Disturbances in the sleep cycle are 
strongly correlated with impaired nocturnal blood pressure dipping (Suzuki et al., 2011), yet 
little is known regarding the effects of acute alcohol consumption on blood pressure 
regulation and sleep architecture in a college age population.  Male college students may be 
at particular risk given that they report greater consumption of alcohol compared to female 
college students (Dawson and Archer, 1992), and male college students’ tend to have 
decreased hemodynamic function compared to their female counterparts (Evans et al., 2001).  
The purpose of this study is to examine the effects of acute alcohol consumption on 
hemodynamics and sleep architecture in a sample of male college students. 
It is hypothesized that acute alcohol consumption will result in an increase in central 
hemodynamics, including an increase in arterial stiffness, which will result in an increase in 
blood pressure.  In regards to sleep architecture, alcohol consumption will disturb sleep 
architecture, which will instigate a rise in nocturnal blood pressure.  The negative impact on 
sleep architecture will facilitate decreases in REM and deep sleep as well as increases in the 
frequency of sleep disturbances (Fung et al., 2011). 
 Cardiovascular diseases such as hypertension and coronary artery disease are leading 
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causes of mortality in the modern world and require expensive testing, treatments, and 
medicines.  The causes and time of onset can vary greatly and developing bodies of data 
showing manifestation of alcohol related effects on the human cardiovascular system will 
help us understand the progression of CVD in young individuals (Dyer et al., 1990), leading 
to effective prevention and treatment options.  These may be in the form of social awareness 
programming highlighting the acute effects of alcohol ingestion and the progression of CVD 
as we age.  The present study may provide information about the effects of alcohol 
consumption on the health of the cardiovascular system and regulating mechanisms.  Also, 
information regarding the acute effect of alcohol on sleep architecture and nocturnal blood 
pressure could further raise the social awareness surrounding these factors.  Achievement of 
dipping blood pressure status reduces the instance for cardiac events and may provide 
knowledge that could result in longer lifespan.  Obtaining information that acute alcohol 
consumption negatively affects multiple health parameters may provide further information 
as to the mechanisms behind the hypertension epidemic. 
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Methods 
Subjects 
For this study, 17 college-aged males (21-25 years old) were recruited.  Exclusion 
criteria included a history of cardiovascular, respiratory, gastrointestinal, renal, or other 
medical condition that would endanger the subject for this study.  Subjects were excluded if 
they were current smokers or currently taking any prescription or over the counter medica-
tions.  All participation was voluntary, and subjects were able to withdraw at any time with-
out penalty.  Each subject was administered a drinking behaviors questionnaire before arri-
val to the lab to determine whether each subject fit inclusion criteria.  This questionnaire 
was administered via telephone.  Upon completion of this questionnaire and inclusion in the 
study, each subject was then instructed to arrive at the lab at the appropriate time.  Partici-
pants were verbally informed of procedures, risks, and benefits of the study before giving 
their written informed consent for participation.  Before participating in the study, subjects 
completed a health history questionnaire (including demographic information). 
Experimental Procedure 
Subjects were recruited from the male student body of Appalachian State University 
via a campus-wide email.  Those who replied to the email took part in a drinking behaviors 
questionnaire via telephone to determine whether they fit inclusion criteria.  Potential sub-
jects were instructed to maintain regular diet and forego exercise on testing days.  Potential 
subjects (N = 17) who met inclusion criteria and expressed interest in participation were in-
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structed to report to the Vascular Biology and Autonomic Studies Laboratory at Appalachi-
an State University for informed consent, initial testing, and instruction and familiarization 
with the Zeo™ sleep monitor as well as the Oscar2™ ambulatory blood pressure monitor.  
Subjects completed a health history questionnaire upon arrival.  Baseline testing consisted of 
height, weight, blood pressure (BP), body composition via Bioelectrical Impedance Analysis 
(BIA), Pulse Wave Analysis (PWA) (Wassertheurer et al. 2010), and Pulse Wave Velocity 
(PWV) (Calabia et al., 2011, Ding et al., 2011).  BP was taken in accordance with American 
Heart Association (AHA) standards. Subjects sat quietly for 15 minutes before BP was tak-
en.  The first and fourth Korotkoff sounds were utilized for systolic and diastolic blood pres-
sure.  Subjects were directed to wear the Zeo™ sleep monitoring system (Shambroom et al., 
2012) and Oscar2™ ambulatory blood pressure monitor (Goodwin et al., 2007) for one night 
in order to achieve a baseline measurement.  The subjects were instructed to maintain their 
regular diet and exclude exercise on testing days.  
Upon completion of this baseline period, subjects arrived at the lab one week later to 
undergo treatment and perform the battery of post treatment hemodynamic testing.  Subjects 
were instructed to eat two hours before reporting to the laboratory.  First, breath alcohol 
concentration (BrAC) was measured and subjects were instructed on alcohol consumption 
treatment. BrAC was taken via the ASIII before alcohol administration to ensure a 0.0 base-
line reading.  Following BrAC, urine specific gravity and anthropometric data were collect-
ed. Participants were administered a single drink of 100 proof vodka mixed in a solution of 1 
part vodka to 4 parts tonic water and lime that was normalized to each subject by body-
weight (2mL/kg of body weight).  Participants were instructed to consume this drink within 
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15 minutes.  This combination has reliably been shown to result in an average blood alcohol 
concentration of .07 to .08 (Poltavski et al., 2011).  Upon arriving at a BAC of 0.08, subjects 
were instructed to wait patiently for 30 minutes.  Thirty minutes post consumption; a second 
round of measurements consisting of BP, PWA, and PWV were taken.  
Upon completion of the measurements, each subject was given another Zeo™ sleep 
monitor as well as Oscar2™ ambulatory blood pressure cuff in order to observe the effects 
of the treatment on sleep and nocturnal BP dipping.  Following testing, subjects were re-
quired to remain in the lab under supervision until BAC returns to a baseline range between 
0.02 and 0.05.  Once this criterion was met, subjects were allowed to leave the lab, released 
to a sober driver of their choice.  All subjects were instructed to maintain their normal rou-
tines with the exception of further alcohol consumption and exercise as well as wearing the 
Zeo™ sleep monitor and Oscar2™ ambulatory blood pressure cuff while they slept.  
Each subject returned to the lab the next morning, 12 hours post consumption and re-
turned the Zeo™ sleep monitors and Oscar2™ ambulatory blood pressure cuffs.  At this 
time, they were re-measured for urine specific gravity, body composition, and completed the 
same hemodynamic measurements as previously performed. 
Tanita BIA 
Body composition and weight (kg) were assessed using Bioelectrical Impedance 
Analysis (Tanita body composition analyzer scale TBF 310, Arlington Heights, IL).  Sub-
jects removed their shoes and socks before stepping on the scale.  Height (cm) was assessed 
using a stadiometer (Health o Meter Professional Standard Beam Scale with Height Rod 
402KL, North Shore Care Supply, Northbrook, IL).  Height was measured while the subjects 
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were standing in the erect position, with shoulders relaxed, arms hanging freely, and heads 
aligned in the Frankfort plane. 
Urine Specific Gravity 
Hydration was measured by asking the subjects to supply a urine sample at the be-
ginning of the second and third lab visits.  The specific gravity of these samples was ana-
lyzed utilizing a refractometer to assess urine specific gravity both before consumption of 
alcohol as well as twelve hours following consumption of alcohol in order to assess hydra-
tion status.  Values exceeding 1.020 were deemed to be dehydrated. 
Alco-Sensor III™ (ASIII) 
The ASIII™ is a hand-held pocket breath alcohol tester.  Participants breathe into 
disposable mouthpieces while their BrAC is displayed on a large three-digit display.  The 
ASIII is capable of measuring BrAC manually, but also is powerful enough to capture BrAC 
from an unconscious person or to detect the alcohol content of a solution. 
History Questionnaire and Demographics 
Demographic information included gender, age, ethnicity, and extracurricular in-
volvement.  An alcohol and substance use questionnaire assessed typical patterns of alcohol 
and drug use via three family history questions and 10 personal use questions.  This included 
one item that assessed the number of days per month the participant drank and one that as-
sessed how much was typically consumed, which was combined multiplicatively to yield the 
average number of drinks consumed per month. 
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Sphygmacor Cardiovascular Management System 
Arterial Pulse Wave Velocity and Aortic Blood Pressure Waveforms (PWV, ABPW respec-
tively)  
All measurements were conducted in accordance with guidelines set forth by the 
Clinical Application of Arterial Stiffness, Task Force III.  The applanation tonometer 
(Sphygmacor, Sydney, Australia) was used to derive the ascending aortic blood pressure 
waveform and a range of central arterial indices.  The Sphygmacor was used with a tonome-
ter over a radial artery calibrated with a standard cuff blood pressure measurement.  In addi-
tion, the PWV (measure of arterial distensibility) module of the Sphygmacor was used to 
obtain indices of arterial stiffness.  The Sphygmacor system is used to obtain the pulse 
wave: (1) between left common carotid artery and the left femoral artery, (2) between the 
left femoral and the ipsilateral dorsalis pedis pulse, and (3) between the left common carotid 
artery and the left radial artery.  Distance from the carotid sampling site to the mid-point of 
the manubrium sterni, manubrium sternum to femoral artery, and femoral artery to dorsalis 
pedis was measured between these points as straight lines with a tape measure.  The distance 
from the carotid artery to the manubrium sterni was subtracted from the manubrium to fem-
oral artery distance.  PWV was determined from the foot-to-foot flow wave velocity.  The 
foot of the pressure wave was identified visually as the point of systolic upstroke.  The time 
delay between a minimum of 15 simultaneously recorded flow waves was averaged.   PWV 
was calculated from the distances between measurement points and the measured time delay 
(Dt) between proximal and distal foot waveforms: PWV = D / Dt (m/s); where D is distance 
in meters and Dt is the time interval in seconds.  Values attained from carotid to femoral ar-
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tery were taken as an index of central compliance, while values attained from the carotid and 
radial artery along with the measurement from the femoral to dorsalis pedis were taken as an 
index of peripheral compliance.  All data was stored and analyzed off-line after completion 
of testing. 
Ambulatory Blood Pressure Measurement (ABPM)  
Upon completion of the initial in-lab testing battery, the subjects were outfitted with 
a SunTech Medical Oscar2™ ambulatory blood pressure device.  This device takes oscilla-
tory blood pressure measurements every 20 minutes throughout the sleep period.  The data 
was stored in the device for later uploading to the VBAS computer. 
Ambulatory Sleep Stage Measurement  
Subjects wore a Zeo™ sleep monitoring headband for one night leading up to test-
ing.  This period was used to establish a baseline with which the testing data was compared.  
The system consists of a soft headband (metallic fibers woven into the material) and a bed-
side display.  The two-piece system utilizes dry sensor EEG technology to transmit brain-
wave data wirelessly to the bedside display, where it was stored for analysis.  During sleep 
episodes between initial testing and 12 hours post testing, subjects also wore the Zeo™ am-
bulatory sleep monitoring headband.  The device is capable of generating data on distinct 
sleep phases (e.g., deep sleep, REM, light sleep, sleep disturbances, sleep onset latency, 
etc.).  The Zeo™ system has been validated against an in-laboratory polysomnography and 
shown to be an accurate and easy way to measure sleep stages. 
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Statistical Analysis 
Repeated measure analysis of variance (ANOVA) was used to determine differences 
between baseline, post-consumption, and 12 hours post-consumption measurements.  Statis-
tical significance was set at p ≤ 0.05.  Statistical analysis was performed using statistical 
analysis software (SPSS, Version 19.0; IBM Corp., Armonk, NY).  Following a significant 
F-ratio, appropriate post-hoc analysis was performed. 
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Results 
Subjects each completed their non-alcohol control session to be compared with their 
individual alcohol data.  All subjects served as their own controls following a baseline 
assessment.  Subject descriptive characteristics are presented in Table 1.  Alcohol had 
various marked effects on the areas of hemodynamics ambulatory blood pressure, and sleep 
architecture.  These findings show baseline measures compared to the post alcohol measures.  
Urine Specific Gravity 
 Twelve hours post-alcohol urine specific gravity and pre-consumption urine specific 
gravity were analyzed and determined to not be statistically different (p > 0.05; Figure 1).  
Hemodynamic Variables 
 Aortic systolic BP values were significantly altered by alcohol.  Compared to 
baseline (104.765 mmHg ±1.905), measures taken 30 minutes post consumption (108.294 
mmHg ± 1.886) showed a significant increase (p < 0.05; Figure 2).  When measures taken 
12 hours post alcohol consumption (109.824 mmHg ± 1.898) were compared to baseline, a 
significant increase was determined (p < 0.05; Figure 2).  No significant differences (p > 
0.05; Figure 3) were determined through augmentation index measurements, though an 
increase was observed following alcohol consumption.  No significant differences were 
determined by aortic pulse pressures.  Central pulse wave velocity and peripheral pulse 
wave velocity also showed no significant differences when comparing baseline, 30 minutes 
post, and 12 hours post consumption measures (all p’s > 0.05). 
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Nocturnal Blood Pressure Variables 
Nocturnal systolic BP increased between pre- and post- consumption of alcohol as 
demonstrated in Figure 4.  Baseline nocturnal systolic BP values (120.847 mmHg ± 3.579) 
were significantly different when compared to nocturnal systolic BP following alcohol 
consumption (134.194 mmHg ± 6.949) (p < 0.05; Figure 4).  Alcohol consumption revealed 
an increase in nocturnal diastolic pressure from baseline (58.354 mmHg ± 2.006) to post 
consumption measures (61.994 mmHg ± 2.551), but these findings were not significant (p > 
0.05; Figure 5).  
Diurnal Blood Pressure Variables 
There were no significant diurnal blood pressure findings (p > 0.05; Figures 4 and 5). 
Diurnal systolic blood pressure (p > 0.05; Figure 4) was non-significantly decreased 
following alcohol consumption (136.118 mmHg ± 3.912) when compared to baseline data 
(141.941 mmHg ± 5.105).  Diurnal diastolic blood pressure showed a non-significant 
pressure decrease following alcohol consumption (70.706 mmHg ± 2.479) when compared 
to baseline (72.706 mmHg ± 3.119) time point (p > 0.05; Figure 5). 
Nocturnal blood pressure dipping 
Though there was a decrease in systolic blood pressure dip as well as diastolic blood 
pressure dip, findings were not significant.  The percent dip for systolic pressure was not 
significantly altered between baseline (11.437 % ± 2.014) and the post alcohol (5.136 % ± 
4.102) measures (p > 0.05; Figure 6).  There was also no significant difference in diastolic 
blood pressure dip between baseline (18.522 % ± 2.473) and the post alcohol (11.818 % ± 
2.756 %) measures (p > 0.05). 
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Sleep Architecture 
Total sleep time was found to be statistically significant (p < 0.05; Figure 7). 
Baseline data (333.882 minutes ± 14.681) was significantly less than post alcohol data 
(394.882 minutes ± 18.626).  Time to sleep between pre- and post-alcohol consumption was 
also statistically significant.  Post alcohol data (16.059 minutes ± 3.185) showed a 
significant (p < 0.05; Figure 8) decrease compared to baseline data (32.529 minutes ± 6.805).  
Time in wake showed no significant difference when comparing baseline (20.235 minutes ± 
6.337) and post alcohol (20.412 minutes ± 4.882).  Number of awakenings was also not 
statistically significant.  The baseline awakenings (4.235 ± 0.076) data compared to post 
alcohol (4.353 ± 0.653) showed no significant difference (Figure 9).  There were no 
significant differences between baseline deep sleep (59.647 minutes ± 0.0143) and post 
alcohol deep sleep (64.941 minutes ± 0.028).  There were no significant differences between 
baseline sleep stage percentages and post alcohol sleep stage percentages (p > 0.05; Figure 
10). 
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Table 1: Descriptive Statistics (n = 17) 
 
  Mean Std. Error 
Height 178.6 2.0 
Weight 78.9 3.8 
BodyFat 17.2 2.3 
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Figure 1: The data shown are urine specific gravities measure via refractometer before 
alcohol consumption as well as 12 hours post alcohol consumption.  The data shown are 
1.021 ± 0.002 and 1.023 ± 0.001.  12 hours post alcohol urine specific gravity and pre 
consumption urine specific gravity were analyzed and determined to be statistically not 
different (p > 0.05).  Data are presented as mean ± SEM. 
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Figure 2: The data shown are aortic systolic pressures measure at baseline, 30 minutes 
following alcohol consumption, and 12 hours following alcohol consumption.  The data 
shown are 104.765 mmHg ±1.905, 109.824 mmHg ± 1.898, and 108.294 mmHg ± 1.886.  
Data are presented as mean ± SEM.  *Significance at p < 0.05 noted at baseline versus 
30mins post as well as baseline versus 12hrs post. 
 
  
            Baseline                30mins Post       12hrs Post 
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Figure 3: The data shown are augmentation indices measured at baseline, 30 minutes 
following alcohol consumption, and 12 hours following alcohol consumption.  The data 
shown are -0.588 % ±2.067, 3.824 % ± 2.039, and 3.000 % ± 2.372.  Data are presented as 
mean % ± SEM.  No significant difference was determined.  
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Figure 4: The data shown are systolic pressures measured at baseline and following alcohol 
consumption.  The data shown are 136.118 mmHg ±3.912, 120.847 mmHg ± 3.579, 141.941 
mmHg ± 5.105, and 134.194 mmHg ± 6.949.  Data are presented as mean ± SEM. 
*Significance at p < 0.05 noted at baseline nocturnal systolic versus nocturnal systolic post 
alcohol.  
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Figure 5: The data shown are diastolic pressures measured at baseline and following alcohol 
consumption.  The data shown are 72.706 mmHg ±3.119, 58.354 mmHg ± 2.006, 70.706 
mmHg ± 2.479, and 61.994 mmHg ± 2.551.  Data are presented as mean ± SEM.  No 
significant differences were determined. 
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Figure 6: The data shown are percentages of blood pressure dip measured at baseline and 
following alcohol consumption.  The data shown are 11.437 % ± 2.014, 18.522 % ± 2.473, 
5.136 % ± 4.102, and 11.818 % ± 2.756.  Data are presented as mean ± SEM.  No significant 
differences were determined.   
 
22 
 
 
 
 
 
 
 
 
Figure 7: The data shown are time (minutes) of total sleep measured at baseline and 
following alcohol consumption.  The data shown are 333.882 minutes ± 14.681 and 394.882 
minutes ± 18.626.  Data are presented as mean ± SEM.  *Significance at p < 0.05 noted at 
baseline total sleep versus post alcohol total sleep. 
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Figure 8: The data shown are times (minutes) measured at baseline and following alcohol 
consumption.  The data shown are 32.529 minutes ± 6.805, 16.059 minutes ± 3.185, 20.235 
minutes ± 6.337, and 20.412 minutes ± 4.882.  Data are presented as mean ± SEM. 
*Significance at p < 0.05 noted at baseline time to sleep versus post alcohol time to sleep. 
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Figure 9: The data shown are number of times awakened measured at baseline and 
following alcohol consumption.  The data shown are 4.235 ± 0.076 and 4.353 ± 0.653.  Data 
are presented as mean ± SEM.  No significant differences were determined. 
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Figure 10: The data shown are percentages measured at baseline and following alcohol 
consumption.  The data shown are 85.118 minutes ± 0.10024, 108.353 minutes ± 0.12038, 
186.941 minutes ± 0.09899, 219.529 minutes ± 0.11382, 59.647 minutes ± 0.0143, and 
64.941 minutes ± 0.028.  Percentages shown are 25.493%, 27.439%, 55.990%, 55.594%, 
17.865%, and 16.446%.  Data are presented as mean ± SEM.  No significant differences 
were determined between baseline sleep stage percentages and post alcohol sleep stage 
percentages. 
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Conclusion 
 The results from the present study show that heavy consumption of alcohol in a 
sample of college age males can have marked effects on both hemodynamics and sleep 
architecture.  It is well known that chronic alcohol consumption contributes to increased 
cardiovascular risk (Lang et al., 1987, Marmot et al. 1994, Puddey et al., 1988); however, no 
studies have been conducted pertaining to acute bouts of binge drinking in a college-aged 
male sample in relation to hemodynamic and sleep architecture variables.  Although at 
baseline, subjects were mildly dehydrated, evidenced by the lack of significant difference in 
urine specific gravities, dehydration may be ruled out as a possible cause for the significant 
differences.  Dehydration has been shown to result in similar findings and has a large impact 
on vascular health and function (Gonzalez-Alonso et al., 1995).  The present results indicate 
that dehydration did not account for the noted differences in hemodynamics. 
As previous research has shown (Foerster et al., 2009, Keil et al., 1989, Wakabayashi 
et al., 2010), alcohol consumption yielded significant results particularly in aortic systolic 
blood pressure.  This study gives a novel view of the effects in that at both time intervals of 
30 minutes post consumption and 12 hours post consumption when compared to baseline 
measures, significant increases in aortic systolic blood pressures were determined.  As 
evidenced, acute alcohol consumption resulted in an increase in systolic pressure that was 
seen throughout the sleeping period and into the following morning.  The full duration of the 
effects from acute alcohol ingestion is still unknown, and future research is needed to 
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expound further on the findings of the present research.  This extended period of increased 
cardiac workload likely has direct effects on the entire cardiovascular system and serves as a 
catalyst for the formation/progression of other risk factors.  Increased aortic systolic pressure 
can increase the likelihood of further arterial stiffening and arterial wall insult (Safarova et 
al., 2012).  Higher aortic systolic pressures can also reduce the sensitivity of pressoreceptors, 
thus further impairing autonomic regulation (Mandyam et al. 2012, Michas et al., 2012, 
Moller et al., 2007, Parati and Esler, 2012). 
Because of increased cardiac workload, risk factors associated with cardiovascular 
disease, specifically hypertension, can be potentiated (Urbina et al., 2011).  Following 
alcohol consumption, nocturnal systolic blood pressure was significantly increased when 
compared to baseline measures.  These data indicate that acute alcohol ingestion results in 
transient hypertension in the aorta.  Because elevated aortic systolic pressures have such a 
strong impact on peripheral circulation, this puts individuals at risk for many hypertension 
related cardiovascular diseases.  Significantly elevated nocturnal blood pressure is highly 
correlated to increased risk of cardiovascular disease (Hansen et al., 2011, Yano and Kario, 
2012a, Yano and Kario, 2012b).  Non-statistically significant increases in diurnal systolic 
pressures as well as diurnal and nocturnal diastolic pressures were observed.  Though 
findings were not significantly different, changes due to alcohol ingestion can have strong 
clinical significance.  Because our findings observed short-term hypertension lasting up to 
12 hours after acute alcohol ingestion, a number of effects can follow ranging from arterial 
insult, directly due to increases in pressure, to impairments in baroreflex sensitivity (Davis et 
al., 2012).  This extended time period of elevated systolic blood pressure can have a marked 
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effect on many aspects of cardiovascular health, particularly arterial compliance and 
autonomic auto-regulation (Michas et al., 2012).  
No significant differences were noted in arterial compliance measures.  When 
comparing pulse wave velocities, a slight change was observed.  Contrary to available 
research, statistical significance was not witnessed.  Because of this, further research is 
needed.  Augmentation index measures revealed a similar situation to pulse wave velocity in 
that changes were observed without obtaining statistical difference.  Because aortic systolic 
pressure and nocturnal blood pressures were significantly elevated when compared to 
baseline, compliance measures such as pulse wave velocity and augmentation index were 
expected to have statistical significance attributed to the difference between baseline and 
post alcohol measures (Lewandowski et al. 2012).  
The present research showed decreases in both nocturnal systolic dip and nocturnal 
diastolic dip (Pall et al., 2012, Sasaki et al., 2012).  No significant differences were 
determined between post-alcohol measures and baseline measures, which can be attributed 
to an outlier in our sample.  This outlier showed effects that were not congruent with the 
mean of the rest of the group, which affected the group mean.  This is likely attributed to 
aerobic training status of the individual, as this variable was not controlled.  Observable 
differences in nocturnal dip were measured, but these differences did not reach statistical 
significance.  Again, though statistical significance was not achieved, clinical importance 
was obtained in that blood pressure dip was greatly reduced, which is highly correlated to 
cardiovascular disease progression (Tsioufis et al., 2011).  
There were no significant findings in this study relating acute alcohol consumption to 
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number of awakenings and time in deep sleep in comparisons of baseline and post alcohol 
consumption, contrary to previous research (Van Reen et al., 2011, Vinson et al., 2010).  One 
significant finding was the difference in time taken to fall asleep.  Alcohol showed a 
significant decrease from baseline data.  This illustrates one common problem associating 
acute alcohol ingestion and sleep.  Alcohol is commonly used as a sleep aid, possibly due to 
the results from this study, which showed reduction in time to sleep, but as evidenced earlier, 
even acute ingestion can result in transient hypertension which progresses risk factors 
associated with CVDs.  This further reiterates the point that alcohol should not be used as a 
sleep aid because acute consumption may have deleterious effects.  Time spent in deep sleep 
and number of awakenings showed no significant difference as previously hypothesized 
(Van Reen et al., 2011, Vinson et al., 2010).  The percentage of time spent in each stage of 
the sleep cycle was not found to be significantly different.  Therefore, the interrelationship 
of how alcohol affects sleep architecture should be studied further. 
The current investigation suggests that an acute bout of heavy alcohol consumption 
among young males may influence the nocturnal BP system and may impact the progression 
of hypertension related cardiovascular disease due to the increase in aortic systolic blood 
pressure.  Progressions of these diseases are being seen at earlier ages and can be 
exacerbated by factors such as alcohol consumption.  The present findings, which showed a 
significant increase in aortic systolic blood pressure and nocturnal systolic blood pressure, 
can be an important mechanism as to how alcohol intensifies the progression of 
hypertension related cardiovascular disease.  These pressure increases can have profound 
effects on many facets of the cardiovascular system.  These effects can range from 
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impairment of autonomic auto-regulatory mechanisms (Davis et al., 2012) to aspects of 
hemodynamics (Lewandowski et al. 2012).  
Limitations 
 The most glaring limitation of this study is that the results only apply to males.  
Further research is needed in order to expound upon how females are affected by acute 
alcohol ingestion.  Another limitation faced during the research process was that subject 
aerobic training status was not controlled.  We did, however, control for exercise throughout 
the duration of the study to exclude any affects brought on by acute exercise.  Another 
limitation can be attributed to a lack of power to detect differences based on the sample size 
(N=17).  A larger sample could result in an observed significance value. 
Future Implications 
 The connection between alcohol use and hypertension is well documented yet the 
mechanism remains elusive.  Many areas of the cardiovascular system are affected and these 
effects have consequences which further impact the system.  This study showed that acute 
ingestion of alcohol can result in increases in aortic pressure, which can have a profound 
impact on the health and functionality of the entire cardiovascular system from a clinical 
perspective (Friedman and Logan, 2009).  An increase in aortic pressure of 4-5mmHg was 
observed 30 minutes post consumption as well as 12 hours post consumption.  Because of 
the extended period in which the aorta was experiencing an increased workload, nocturnal 
brachial blood pressure was also found to be significantly increased.  These changes can 
drastically affect hemodynamics as well as baroreflex sensitivity (Michas et al., 2012, 
Moller et al., 2007) and can occur very early in the cascade of events which progress to 
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cardiovascular disease.  The findings of this study illustrate how a singular acute bout of 
alcohol ingestion can impact risk factors for the development of cardiovascular disease. 
 A single bout of alcohol ingestion resulted in up to 12 hours of elevated aortic 
pressures, which is supported by previous research (Wakabayashi, 2005); however, the 
duration for which these pressures remain elevated is still unknown.  Future research is 
needed to determine the duration of aortic systolic pressure as well as any other risk factors 
for the progression of cardiovascular disease.  More research observing nocturnal blood 
pressure dipping following an acute bout of alcohol ingestion is also needed.  It may be that 
this period of increased aortic pressure is the direct mechanism behind baroreceptor blunting 
which diminishes the presence of a nocturnal blood pressure dip following acute ingestion of 
alcohol in a young healthy cohort of men. 
  
 
32 
 
 
 
 
 
 
References 
Arnedt, J. T., Rohsenow, D. J., Almeida, A. B., Hunt, S. K., Gokhale, M., Gottlieb, D. J. & 
Howland, J. 2011. Sleep following alcohol intoxication in healthy, young adults: 
effects of sex and family history of alcoholism. Alcohol Clin Exp Res, 35, 870-8. 
Calabia, J., Torguet, P., Garcia, M., Garcia, I., Martin, N., Guasch, B., Faur, D. & Valles, M. 
2011. Doppler ultrasound in the measurement of pulse wave velocity: agreement 
with the Complior method. Cardiovasc Ultrasound, 9, 13. 
Crum, R. M., Storr, C. L., Chan, Y. F. & Ford, D. E. 2004. Sleep disturbance and risk for 
alcohol-related problems. Am J Psychiatry, 161, 1197-203. 
Cuspidi, C., Sala, C., Valerio, C., Negri, F. & Mancia, G. 2011. Nocturnal blood pressure in 
untreated essential hypertensives. Blood Press, 20, 335-41. 
Davis, J. T., Rao, F., Naqshbandi, D., Fung, M. M., Zhang, K., Schork, A. J., Nievergelt, C. 
M., Ziegler, M. G. & O'Connor, D. T. 2012. Autonomic and hemodynamic origins of 
pre-hypertension: central role of heredity. J Am Coll Cardiol, 59, 2206-16. 
Dawson, D. A., & Archer, L. 1992. Gender differences in alcohol consumption: effects of 
measurement. British Journal of Addiction, 87(1), 119-123. 
Ding, F. H., Fan, W. X., Zhang, R. Y., Zhang, Q., Li, Y. & Wang, J. G. 2011. Validation of 
the noninvasive assessment of central blood pressure by the SphygmoCor and 
Omron devices against the invasive catheter measurement. Am J Hypertens, 24, 
1306-11. 
Dyer, A. R., Cutter, G. R., Liu, K. Q., Armstrong, M. A., Friedman, G. D., Hughes, G. H., 
Dolce, J. J., Raczynski, J., Burke, G. & Manolio, T. 1990. Alcohol intake and blood 
pressure in young adults: the CARDIA Study. J Clin Epidemiol, 43, 1-13. 
Ehlers, C. L., Gilder, D. A., Criado, J. R. & Caetano, R. 2010. Sleep quality and alcohol-use 
disorders in a select population of young-adult Mexican Americans. J Stud Alcohol 
Drugs, 71, 879-84. 
Evans, J. M., Ziegler, M. G., Patwardhan, A. R., Ott, J. B., Kim, C. S., Leonelli, F. M., & 
Knapp, C. F. 2001. Gender differences in autonomic cardiovascular regulation: 
spectral, hormonal, and hemodynamic indexes. Journal of Applied Physiology, 
91(6), 2611-2618. 
Foerster, M., Marques-Vidal, P., Gmel, G., Daeppen, J. B., Cornuz, J., Hayoz, D., Pecoud, 
A., Mooser, V., Waeber, G., Vollenweider, P., Paccaud, F. & Rodondi, N. 2009. 
Alcohol drinking and cardiovascular risk in a population with high mean alcohol 
consumption. Am J Cardiol, 103, 361-8. 
Friedman, O. & Logan, A. G. 2009. Nocturnal blood pressure profiles among normotensive, 
controlled hypertensive and refractory hypertensive subjects. Can J Cardiol, 25, 
e312-6. 
 
33 
 
 
 
 
Fung, M. M., Peters, K., Redline, S., Ziegler, M. G., Ancoli-Israel, S., Barrett-Connor, E. & 
Stone, K. L. 2011. Decreased slow wave sleep increases risk of developing 
hypertension in elderly men. Hypertension, 58, 596-603. 
Gillman, M. W., Cook, N. R., Evans, D. A., Rosner, B. & Hennekens, C. H. 1995. 
Relationship of alcohol intake with blood pressure in young adults. Hypertension, 
25, 1106-10. 
Gonzalez-Alonso, J., Mora-Rodriguez, R., Below, P. R., & Coyle, E. F. 1995. Dehydration 
reduces cardiac output and increases systemic and cutaneous vascular resistance 
during exercise. Journal of Applied Physiology, 79(5), 1487-1496. 
Goodwin, J., Bilous, M., Winship, S., Finn, P. & Jones, S. C. 2007. Validation of the Oscar 
2 oscillometric 24-h ambulatory blood pressure monitor according to the British 
Hypertension Society protocol. Blood Press Monit, 12, 113-7. 
Gray, L., Lee, I. M., Sesso, H. D. & Batty, G. D. 2011. Blood pressure in early adulthood, 
hypertension in middle age, and future cardiovascular disease mortality: HAHS 
(Harvard Alumni Health Study). J Am Coll Cardiol, 58, 2396-403. 
Hansen, T. W., Li, Y., Boggia, J., Thijs, L., Richart, T. & Staessen, J. A. 2011. Predictive 
role of the nighttime blood pressure. Hypertension, 57, 3-10. 
Higashyama, A., Okamura, T., Watanabe, M., Kokubo, Y., Wakabayashi, I., Okayama, A. & 
Miyamoto, Y. 2012. Alcohol consumption and cardiovascular disease incidence in 
men with and without hypertension: the Suita study. Hypertens Res. 
Keil, U., Chambless, L. & Remmers, A. 1989. Alcohol and blood pressure: results from the 
Luebeck Blood Pressure Study. Prev Med, 18, 1-10. 
Kochanek, K. D., Minino, A. M., Murphy, S. L., Xu, J. & Kung, H.-C. 2011. Deaths: final 
data for 2009, Department of Health and Human Services, Centers for Disease 
Control and Prevention, National Center for Health Statistics. 
Kurihara, T., Tomiyama, H., Hashimoto, H., Yamamoto, Y., Yano, E. & Yamashina, A. 
2004. Excessive alcohol intake increases the risk of arterial stiffening in men with 
normal blood pressure. Hypertens Res, 27, 669-73. 
Lanfranchi, P. A., Pennestri, M. H., Fradette, L., Dumont, M., Morin, C. M. & Montplaisir, 
J. 2009. Nighttime blood pressure in normotensive subjects with chronic insomnia: 
implications for cardiovascular risk. Sleep, 32, 760-6. 
Lang, T., Degoulet, P., Aime, F., Devries, C., Jacquinet-Salord, M. C. & Fouriaud, C. 1987. 
Relationship between alcohol consumption and hypertension prevalence and control 
in a French population. J Chronic Dis, 40, 713-20. 
Le-Ha, C., Beilin, L. J., Burrows, S., Huang, R. C., Oddy, W. H., Hands, B. & Mori, T. A. 
2012. Oral contraceptive use in girls and alcohol consumption in boys are associated 
with increased blood pressure in late adolescence. Eur J Prev Cardiol. 
Lewandowski, J., Artyszuk, L., Ostrowski, F., Ciszewski, J., Puchalska, L. & Abramczyk, P. 
2012. Individuals with high-normal blood pressure have different metabolic and 
haemodynamic characteristics to those with optimal blood pressure. Kardiol Pol, 70, 
252-8. 
Mandyam, M. C., Vedantham, V., Scheinman, M. M., Tseng, Z. H., Badhwar, N., Lee, B. 
K., Lee, R. J., Gerstenfeld, E. P., Olgin, J. E. & Marcus, G. M. 2012. Alcohol and 
vagal tone as triggers for paroxysmal atrial fibrillation. Am J Cardiol, 110, 364-8. 
 
34 
 
 
 
 
Marmot, M. G., Elliot, P., Shipley, M. J., Dyer, A. R., Ueshima, H., Beevers, D. G., Stamler, 
R., Kesteloot, H., Rose, G. & Stamler, J. 1994. Alcohol and blood pressure: the 
INTERSALT study. BMJ, 308, 1263-7. 
Matthews, K. A., Kamarck, T. W., M, H. H., Strollo, P. J., Owens, J. F., Buysse, D. J., Lee, 
L. & Reis, S. E. 2008. Blood pressure dipping and sleep disturbance in African-
American and Caucasian men and women. Am J Hypertens, 21, 826-31. 
Mehta, R. & Drawz, P. E. 2011. Is nocturnal blood pressure reduction the secret to reducing 
the rate of progression of hypertensive chronic kidney disease? Curr Hypertens Rep, 
13, 378-85. 
Michas, F., Manios, E., Stamatelopoulos, K., Koroboki, E., Toumanidis, S., Panerai, R. B. & 
Zakopoulos, N. 2012. Baroreceptor reflex sensitivity is associated with arterial 
stiffness in a population of normotensive and hypertensive patients. Blood Press 
Monit, 17, 155-9. 
Moller, S., Iversen, J. S., Henriksen, J. H. & Bendtsen, F. 2007. Reduced baroreflex 
sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems. 
Am J Physiol Heart Circ Physiol, 292, H2966-72. 
Napan, S., Kwagyan, J., Randall, O. S., Xu, S., Ketete, M. & Maqbool, A. R. 2011. 
Nocturnal blood pressure nondipping in obese African-Americans. Blood Press 
Monit, 16, 111-6. 
Ohmori, S., Kiyohara, Y., Kato, I., Kubo, M., Tanizaki, Y., Iwamoto, H., Nakayama, K., 
Abe, I. & Fujishima, M. 2002. Alcohol intake and future incidence of hypertension 
in a general Japanese population: the Hisayama study. Alcohol Clin Exp Res, 26, 
1010-6. 
Pajak, A. & Kawalec, E. 2005. Lifestyle characteristics and hypertension in the middle-aged 
population of Krakow. Blood Press Suppl, 2, 17-21. 
Pall, D., Kiss, I. & Katona, E. 2012. Importance of ambulatory blood pressure monitoring in 
adolescent hypertension. Kidney Blood Press Res, 35, 129-34. 
Parati, G. & Esler, M. 2012. The human sympathetic nervous system: its relevance in 
hypertension and heart failure. Eur Heart J, 33, 1058-66. 
Poltavski, D. V., Marino, J. M., Guido, J. M., Kulland, A., & Petros, T. V. 2011. Effects of 
acute alcohol intoxication on verbal memory in young men as a function of time of 
day. Physiology & behavior, 102(1), 91-95. 
Puddey, I. B., Jenner, D. A., Beilin, L. J. & Vandongen, R. 1988. An appraisal of the effects 
of usual vs recent alcohol intake on blood pressure. Clin Exp Pharmacol Physiol, 15, 
261-4. 
Sabanayagam, C. & Shankar, A. 2010. Sleep duration and cardiovascular disease: results 
from the National Health Interview Survey. Sleep, 33, 1037-42. 
Safarova, A. F., Iurtaeva, V. R., Kotovskaia IU, V. & Kobalava ZH, D. 2012. [The state of 
carotid arteries in young men with arterial hypertension]. Kardiologiia, 52, 22-5. 
Sasaki, M., Ando, H. & Fujimura, A. 2012. Lack of nocturnal blood pressure fall in elderly 
bedridden hypertensive patients with cerebrovascular disease. Chronobiol Int, 29, 
62-5. 
Seppa, K. & Sillanaukee, P. 1999. Binge drinking and ambulatory blood pressure. 
Hypertension, 33, 79-82. 
 
35 
 
 
 
 
Shambroom, J. R., Fabregas, S. E. & Johnstone, J. 2012. Validation of an automated 
wireless system to monitor sleep in healthy adults. J Sleep Res, 21, 221-30. 
Sherwood, A., Routledge, F. S., Wohlgemuth, W. K., Hinderliter, A. L., Kuhn, C. M. & 
Blumenthal, J. A. 2011. Blood pressure dipping: ethnicity, sleep quality, and 
sympathetic nervous system activity. Am J Hypertens, 24, 982-8. 
Steffens, A. A., Moreira, L. B., Fuchs, S. C., Wiehe, M., Gus, M. & Fuchs, F. D. 2006. 
Incidence of hypertension by alcohol consumption: is it modified by race? J 
Hypertens, 24, 1489-92. 
Sull, J. W., Yi, S. W., Nam, C. M., Choi, K. & Ohrr, H. 2010. Binge drinking and 
hypertension on cardiovascular disease mortality in Korean men and women: a 
Kangwha cohort study. Stroke, 41, 2157-62. 
Sunagawa, K. 2010. The pressure-volume relationship of the heart: past, present and future. 
Conf Proc IEEE Eng Med Biol Soc, 2010, 3554-5. 
Sundell, L., Salomaa, V., Vartiainen, E., Poikolainen, K. & Laatikainen, T. 2008. Increased 
stroke risk is related to a binge-drinking habit. Stroke, 39, 3179-84. 
Suzuki, R., Meguro, M. & Meguro, K. 2011. Sleep disturbance is associated with decreased 
daily activity and impaired nocturnal reduction of blood pressure in dementia 
patients. Arch Gerontol Geriatr, 53, 323-7. 
Tsioufis, C., Andrikou, I., Thomopoulos, C., Syrseloudis, D., Stergiou, G. & Stefanadis, C. 
2011. Increased nighttime blood pressure or nondipping profile for prediction of 
cardiovascular outcomes. J Hum Hypertens, 25, 281-93. 
Urbina, E. M., Khoury, P. R., McCoy, C., Daniels, S. R., Kimball, T. R. & Dolan, L. M. 
2011. Cardiac and vascular consequences of pre-hypertension in youth. J Clin 
Hypertens (Greenwich), 13, 332-42. 
Van de Borne, P., Mark, A. L., Montano, N., Mion, D. & Somers, V. K. 1997. Effects of 
alcohol on sympathetic activity, hemodynamics, and chemoreflex sensitivity. 
Hypertension, 29, 1278-83. 
Van Reen, E., Tarokh, L., Rupp, T. L., Seifer, R. & Carskadon, M. A. 2011. Does timing of 
alcohol administration affect sleep? Sleep, 34, 195-205. 
Vasunta, R. L., Kesaniemi, Y. A., Ylitalo, A. & Ukkola, O. 2012. Nondipping pattern and 
carotid atherosclerosis in a middle-aged population: OPERA Study. Am J Hypertens, 
25, 60-6. 
Vinson, D. C., Manning, B. K., Galliher, J. M., Dickinson, L. M., Pace, W. D. & Turner, B. 
J. 2010. Alcohol and sleep problems in primary care patients: a report from the 
AAFP National Research Network. Ann Fam Med, 8, 484-92. 
Wakabayashi, I. 2005. Sensitivity of circulatory response to alcohol influences the 
relationship between alcohol consumption and blood pressure in Orientals. Blood 
Press, 14, 238-44. 
Wakabayashi, I. & Araki, Y. 2010. Influences of gender and age on relationships between 
alcohol drinking and atherosclerotic risk factors. Alcohol Clin Exp Res, 34 Suppl 1, 
S54-60. 
 
 
 
36 
 
 
 
 
Wassertheurer, S., Kropf, J., Weber, T., Van Der Giet, M., Baulmann, J., Ammer, M., 
Hametner, B., Mayer, C. C., Eber, B. & Magometschnigg, D. 2010. A new 
oscillometric method for pulse wave analysis: comparison with a common 
tonometric method. J Hum Hypertens, 24, 498-504. 
Yano, Y. & Kario, K. 2012a. Nocturnal blood pressure and cardiovascular disease: a review 
of recent advances. Hypertens Res, 35, 695-701. 
Yano, Y. & Kario, K. 2012b. Nocturnal blood pressure, morning blood pressure surge, and 
cerebrovascular events. Curr Hypertens Rep, 14, 219-27. 
Yoshita, K., Miura, K., Morikawa, Y., Ishizaki, M., Kido, T., Naruse, Y., Soyama, Y., 
Suwazono, Y., Nogawa, K. & Nakagawa, H. 2005. Relationship of alcohol 
consumption to 7-year blood pressure change in Japanese men. J Hypertens, 23, 
1485-90. 
  
 
37 
 
 
 
 
 
 
Appendix A 
  
 
38 
 
 
 
 
 
From: Dr. Stan Aeschleman, Institutional Review Board Chairperson  
RE: Notice of IRB Approval by Full Board Review  
Study #: 13-0116  
 
Study Title: Sleep, Individual Differences, Blood Flow, and Alcohol Use in College Males  
Submission Type: Initial  
Approval Date: 2/18/2013  
Expiration Date of Approval: 11/19/2013  
 
This submission has been approved by the above IRB for the period indicated above.  
 
Investigator’s Responsibilities:  
 
Federal regulations require that all research be reviewed at least annually. It is the Principal 
Investigator’s responsibility to submit for renewal and obtain approval before the expiration 
date. You may not continue any research activity beyond the expiration date without IRB 
approval. Failure to receive approval for continuation before the expiration date will result 
in automatic termination of the approval for this study on the expiration date.  
 
You are required to obtain IRB approval for any changes to any aspect of this study before 
they can be implemented except to eliminate apparent immediate hazards. Should any 
adverse event or unanticipated problem involving risks to subjects occur it must be reported 
immediately to the IRB. Best wishes with your research!   
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Consent to Participate in Research 
Information to Consider About this Research 
 
Alcohol Use, Individual Differences, and Sleep in College Males 
 
Principal Investigators: Jacqueline Belhumeur; Daniel Payseur 
Department: Psychology; Health, Leisure, and Exercise Science 
Contact Information: belhumeurjr@appstate.edu; dp76043@appstate.edu  
Faculty Advisers: Lisa Curtin (curtinla@appstate.edu) and Scott Collier (colli-
ersr@appstat.edu)  
 
What is the purpose of this research? 
The specific purpose of this study is to explore the relationships between blood pressure, 
individual differences (i.e., social, emotional, and behavioral differences), sleep, and alcohol 
use in college males.  It is the intent of the primary investigators to write two Master’s the-
ses based upon the results of this study and to publish and present the results of this study 
in academic journals and at professional conferences.  
 
Why am I being invited to take part in this research?  
You are invited to participate because you are a healthy male between the ages of 21 and 
25 years with no history of cardiovascular or other medical conditions or regular nicotine 
use.  Additionally, you are not currently on any prescription medications that would be com-
plicated by alcohol use and have previously consumed four alcoholic beverages in one sit-
ting.  You also have not been diagnosed with an alcohol use disorder and are not currently 
receiving any form of psychological service.  A screening for alcohol abuse and depend-
ence will be conducted before admitting you into the study.  If you volunteer to take part in 
this study, you will be one of 25 males to do so.    
 
What will I be asked to do? 
The research procedures will be conducted at the Vascular Biology and Autonomic Studies 
Laboratory at the Blue Cross Blue Shields of North Carolina Institute for Health and Human 
Services on University Hall Drive in room 186C.   
 
You already participated in the brief telephone interview and were informed that we would 
ask you to: 
 Stop taking all over-the-counter medications and supplements for 72 hours prior to 
today and for the duration of the study 
 Not consume alcohol 24 hours prior to today and to not drink alcohol during your 
time in the study (except for when we ask you to drink alcohol during the next lab 
visit) 
 Bring a government-issues photo identification listing your birth date 
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In addition to the above: 
 You will need to come here 3 times (today and two other days) over the course of 3-
5 days (depending on your schedule) for a total of approximately 350 minutes or 5 
hours and 50 minutes .  
 You will need to continue  abstaining from over-the-counter medications and sup-
plements for the duration of the study 
 You will need to abstain from exercise on days you visit the lab.   
 You will not consume alcohol throughout the duration of the study (3-5 days) with 
the exception of the next visit to the laboratory when we will ask you to consume  al-
cohol.   
 
Here is a summary of what to expect during each lab visit: 
 
First Session 
The first visit will take approximately 80 minutes or 1 hour and 20 minutes.  During this visit, 
we will conduct a series of noninvasive blood pressure tests, including pulse wave velocity, 
pulse wave analysis, and reactive hyperemia.  This is so we can get an idea of how eff i-
ciently your blood moves throughout your body.  At this time, you will also be given instruc-
tions on an ambulatory blood pressure cuff and a ZEO sleep band. This is so we can moni-
tor the flow of your blood and the quality of your sleep over the course of a night before the 
alcohol consumption session at your second visit. You will be asked to provide a urine 
sample for assessment of hydration. You will be asked to wear both of these noninvasive 
devices while sleeping the night before your second lab visit (even if this is not the day im-
mediately after your first lab visit).  You will need to agree to have a friend drive you to the 
next session, or agree to take the AppalCart/taxi to and from the lab for the next session. 
You will receive $10 for your time. 
 
Second Session 
After 1-3 nights, you will return to the Vascular Biology and Autonomic Studies Laboratory 
for a second time at 5:30pm.  You will also be asked to eat something two hours before ar-
riving.  Food bars and juice will be available in the event that you do not eat. This visit will 
take approximately 180 minutes or 3 hours and will involve the same blood pressure tests 
as before (i.e. pulse wave velocity, pulse wave analysis, and reactive hyperemia), additional 
biological measurements (i.e. height, weight, blood pressure, and body composition), and a 
series of individual differences measurements (i.e. personality, stress, socialization, sleep, 
and alcohol-related questions).  At this time, you will also be asked to fill out a demographic 
questionnaire.  Finally, you will be asked to consume enough alcohol so that your blood al-
cohol content reaches approximately .08.  This is the equivalent of three to five drinks for 
most males.  These drinks will consist of one part vodka and four parts tonic water and 
lime.  Again, we ask that you not volunteer for this study if you have never consumed four 
alcoholic beverages in one sitting.  Following the alcohol administration, you will be required 
to stay at the lab until your blood alcohol content returns to .02-.04, at which time we will 
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release you to a sober driver or escort you to the AppalCart which runs from the lab to the 
ASU campus until 9:09 PM.  We will ascertain your blood alcohol concentration by having 
you blow into a handheld breathalyzer. We will also measure your blood pressure, pulse 
wave velocity, and reactive hyperemia after alcohol administration, in addition to assessing 
your hydration level via urinanalysis.  You will be asked to wear the ambulatory blood pres-
sure cuff and ZEO sleep band for a final night and return to the lab in the morning.  This is 
so we can see how the alcohol affected your blood pressure and sleep following alcohol 
consumption.  You will receive $20 for your time. 
 
Third Session 
Your third and final visit will take approximate 60 minutes or 1 hour.  At this time you will be 
asked to return your ambulatory blood pressure cuff and ZEO sleep monitor.  You will be 
asked to provide a urine sample for assessment of hydration.We will also conduct pulse 
wave velocity, pulse wave analysis, and reactive hyperemia tests for a final time. You will 
receive $10 for your time.  
 
 
What are possible harms or discomforts that I might experience during the 
research? 
To the best of our knowledge, the risk of harm and discomfort from participating in this re-
search study is slightly more than you would experience in everyday life.  Alcohol consump-
tion will take place in a supervised laboratory setting and you will not be released until your 
blood alcohol content has returned to a safe level, as defined by the National Institute on 
Alcohol Abuse and Alcoholism.  Additionally, you will not be allowed to operate a motor ve-
hicle following the administration to prevent the risk of harming yourself or others; you will 
not be on any concurrent medications to prevent possible detrimental drug interactions; and 
you will be required to eat beforehand so that you are not drinking on an empty stomach.  
All measurements used in the lab are noninvasive and will cause no physiological harm.  
You may also experience some personal discomfort as you reflect upon your blood pres-
sure feedback or responses to questionnaires.  You have the right not to answer any indi-
vidual questions.  Finally, there is some risk that confidentiality could be breached but many 
safeguards are in place to prevent such harm (see below for list of precautions). 
 
Measures 
 
Body Composition Testing:  
There are no known risks associated with this measure.  It is essentially the same as step-
ping on a bathroom scale at home.   
 
Reactive Hyperemia:   
No substantial risks are associated with reactive hyperemia.  Subjects may feel some dis-
comfort in their arm during the portion of the test when blood is occluded to the arm.  The 
sensation is similar to the "pins and needles" individuals feel if their arm "falls asleep." This 
feeling will immediately disappear once the occluding pressure cuff is released and blood 
flow returns to normal.  This is a common technique employed to determine vascular func-
tion, and 5 minutes of occlusion is the minimum amount of time needed to yield accurate 
measures.  No tissue damage is associated with this method. 
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Pulse wave velocity:   
There are no known risks associated with the Doppler ultrasounds used in this technique.  
A small Doppler sensor will be placed on the surface of the skin against the arteries in your 
neck, wrist, upper thigh, and ankle.  The sensor uses ultrasound to measure the direction 
and speed of blood flow through an artery. No physical discomfort should be experienced 
during this assessment.  Patient privacy will be upheld through the use of a curtain during 
the assessment of the femoral artery, as this is located near the pubic area.  
 
Electrocardiography (ECG):   
There are no known risks associated with standard ECG. A series of sensors will be placed 
on your chest.  Trained technicians will perform all ECG preparation and measurements. 
Again, care will be taken to uphold patient privacy during preparation and assessments, as 
the chest area will need to be somewhat exposed for electrode placement. 
 
Urine Specific Gravity (hydration assessment):  
There are no known risks associated with Urine Specific Gravity. The specific gravity of 
these samples will be analyzed utilizing a refractometer to assess urine specific gravity.  
Once the urine sample has been analyzed for hydration it will then be immediately de-
stroyed. 
Ambulatory Sleep Monitoring:   
Minor risk of discomfort is possible wearing the soft-fabric ZeoTM headband while sleeping.  
Because metallic fibers are used in the ZeoTM headband to transmit brainwave data, there 
is risk of skin rash or reaction in individuals who may be allergic to metals.  Subjects will be 
informed to remove the device in such a case and contact one of the investigators. 
 
Ambulatory Blood Pressure Assessment:  
There are no known risks associated with ambulatory blood pressure assessment.  A small 
cuff is placed around the upper arm and it is inflated similar to an arm blood pressure cuff.  
Subjects will be asked to wear this as they sleep.  Subjects may feel slight discomfort in 
their arm with this cuff but this will disappear almost immediately when the cuff is released.  
A trained technician will demonstrate and fit the cuff for each subject. 
 
AlkoSensor: 
The AlkoSensor is a handheld breathalyzer.  You will be asked to breathe into a disposable 
plastic tube for a few seconds and your breath alcohol content will be displayed on a dis-
play screen. 
 
Are there any reasons you might take me out of the research?  
If you do not use the ambulatory blood pressure cuff or ZEO sleep band as directed, we will 
have to remove you from the study.  Additionally, if you cannot abstain from alcohol for 24 
hours prior to initial testing as well as the duration of this study (3-5 days) we will have to 
remove you from the study.   Also, abstaining from all prescription medications for 72 hours 
prior to the study and abstaining from exercise on lab days is required. Inability to do so will 
prompt your removal from the study.  Finally, if you become uncomfortable at any point 
throughout the study, you may leave the study without penalty. You cannot, however, leave 
the lab after consuming alcohol until your BAC returns to a safe level and we know you 
have safe transportation. 
 
 
44 
 
 
 
 
What are possible benefits of this research? 
By participating in this research, you may benefit by learning about the health of your cardi-
ovascular system and how you react to alcohol.  Additionally, the information gained from 
this research will enhance our understanding of the interrelation of blood pressure, alcohol, 
sleep, and individual differences.   
 
Will I be paid for taking part in the research? 
We will pay you for you for the time you volunteer while being in this study.  You will receive 
$10 for your first and third visits and $20 for your second visit, for a total of $40 for your par-
ticipation.  You will receive payment each time you arrive at the lab.   
 
What will it cost me to take part in this research?  
It will not cost you any money to be a part of this research.  Parking at the lab is free, as is 
the AppalCart.  Recall that you may not drive to the second session, but must take the bus, 
a taxi, or have a friend drive you. 
 
What if I get sick or hurt while participating in this research study?  
If you need emergency care while you are at the research site, it will be provided to you. If 
you get hurt or sick when you are not at the research site, you should call your doctor or call 
911 in an emergency.  If your illness or injury could be related to the research, tell the doc-
tors, or emergency room staff about the research study, the name of the Principal Investiga-
tors, and provide a copy of this consent form if possible.  Call Jacqueline Belhumeur, at 
(804) 475-5503 or Daniel Payseur at (704) 530-8679 as soon as you can to let them know 
that you are hurt or ill.  Please exercise caution regarding all activities regarding the alcohol 
administration session. 
 
How will you keep my private information confidential? 
Your information will be combined with information from other people taking part in the 
study. When we write up the study to share it with other researchers, we will write about the 
combined information. You will not be identified in any published or presented materials.  All 
data entry and analysis will be conducted with statistical programs without using identifying 
information.  Additionally, your identifiable information will be stored in a separate building 
from the rest of your information and will be deleted after three years.  Your files, without 
identifying information, will be stored in the Vascular, Biological, and Autonomic Studies 
Laboratory office under lock and key.  
 
Whom can I contact if I have a question? 
The people conducting this study will be available to answer any questions concerning this 
research, now or in the future.  You may contact the Principal Investigators at (704) 530-
8679 (Daniel Payseur) or at (804) 475-5503 (Jackie Belhumeur).  If you have questions 
about your rights as someone taking part in research, contact the Appalachian Institutional 
Review Board Administrator at 828-262-2130 (days), through email at irb@appstate.edu or 
at Appalachian State University, Office of Research and Sponsored Programs, IRB Admin-
istrator, Boone, NC 28608. 
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Do I have to participate?   
Your participation in this research is completely voluntary.  If you choose not to volunteer, 
there is no penalty or consequence.  If you decide to take part in the study you can still de-
cide at any time that you no longer want to participate. You will not lose any benefits or 
rights you would normally have if you do not participate in the study. 
This research project has been approved on 2/18/2013 by the Institutional Review Board 
(IRB) at Appalachian State University.  This approval will expire on 11/19/2013 unless the 
IRB renews the approval of this research. 
 
I have decided I want to take part in this research.  What should I do now? 
Please indicate how you plan to get home at the end of the alcohol administration (second) 
session by checking one of the choices below: 
____ Friend 
____ AppalCart 
____ Taxi 
If you have read this form, had the opportunity to ask questions about the research and re-
ceived satisfactory answers, and want to participate, then sign the consent form and keep a 
copy for your records.  
 
             
Participant's Name (PRINT)                                 Signature                            Date   
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